Dr Katherine Pumphrey joins Ethics Talk to discuss her article, coauthored with Dr Jessica Hart: “What the COVID-19 Pandemic Teaches Us About Pediatric Iatrogenic Risk.”

Dr Amy B. Cadwallader joins Ethics Talk to discuss her article, coauthored with Kavitha Nallathambi: “How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?”

Research questions must be answered to inform policy decisions about the hereditary diseases and conditions for which newborns should be tested.

Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision.

U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.

U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.

U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.

Pediatricians have been forced to navigate diagnostic uncertainty, hospital closures, limited staffing, and new infection control guidelines.

Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains.